In a report released on January 25, Shagun Singh Chadha from RBC Capital maintained a Buy rating on Intuitive Surgical (ISRG – Research Report), with a price target of $305.00. The company’s shares closed yesterday at $247.26.
According to TipRanks, Singh Chadha is a 2-star analyst with an average return of 0.0% and a 47.50% success rate. Singh Chadha covers the Healthcare sector, focusing on stocks such as Abbott Labs, Penumbra, and Edwards Lifesciences.
In addition to RBC Capital, Intuitive Surgical also received a Buy from Raymond James’s Jayson Bedford in a report issued on January 26. However, on January 25, Deutsche Bank maintained a Hold rating on Intuitive Surgical (NASDAQ: ISRG).
See the top stocks recommended by analysts >>
Based on Intuitive Surgical’s latest earnings release for the quarter ending December 31, the company reported a quarterly revenue of $1.66 billion and a net profit of $324.9 million. In comparison, last year the company earned a revenue of $1.55 billion and had a net profit of $380.6 million
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Intuitive Surgical, Inc. manufactures and develops robotic-assisted products, most notably with the da Vinci surgical system and related instruments and accessories, to improve clinical outcomes of patients through minimally invasive surgery. Its products include Da Vinci and Ion. The company was founded in 1995 and is headquartered in Sunnyvale, California.
Read More on ISRG:
- 3 Fantastic High-Growth Stocks Analysts are Bullish On
- Intuitive Surgical price target raised to $245 from $230 at Deutsche Bank
- Intuitive Surgical price target lowered to $279 from $316 at BTIG
- Intuitive Surgical price target lowered to $300 from $310 at Truist
- Intuitive Surgical price target lowered to $289 from $305 at Wells Fargo
